Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gossamer Bio Inc
(NQ:
GOSS
)
1.170
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
25
Open
1.170
Bid (Size)
1.100 (5)
Ask (Size)
1.190 (1)
Prev. Close
1.170
Today's Range
1.170 - 1.170
52wk Range
0.4525 - 1.880
Shares Outstanding
75,993,532
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
March 12, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
March 06, 2024
Via
Benzinga
Performance
YTD
+20.62%
+20.62%
1 Month
-7.87%
-7.87%
3 Month
+32.98%
+32.98%
6 Month
+47.76%
+47.76%
1 Year
-7.14%
-7.14%
More News
Read More
GOSS Stock Earnings: Gossamer Bio Meets EPS for Q4 2023
March 05, 2024
Via
InvestorPlace
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
March 05, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
January 08, 2024
Via
Benzinga
Recap: Gossamer Bio Q3 Earnings
November 09, 2023
Via
Benzinga
Analyst Expectations for Gossamer Bio's Future
August 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 20, 2024
Via
Benzinga
7 Micro-Cap Stocks That Could Majorly Surprise Investors
January 31, 2024
Via
InvestorPlace
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 08, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
December 18, 2023
Via
Benzinga
Analyst Ratings for Gossamer Bio
July 26, 2023
Via
Benzinga
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 18, 2023
Via
Benzinga
Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023
December 13, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Appoints Bob Smith as Chief Commercial Officer
December 05, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
November 29, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 15, 2023
Via
Benzinga
Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying
November 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
November 09, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs
October 03, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023
September 07, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
August 08, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results
July 24, 2023
From
Gossamer Bio, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.